GRECLAV 228 MG / 5 ML(AMOXICILLIN 200 MG + CLAVULANIC ACID 28.5 MG) ORAL SUSPENSION BP

NAFDAC REG. NUMBER: B4-4279

COMPOSITION: Each 5 ml of reconstituted suspension contains 200 mg of Amoxicillin as Amoxicillin Trihydrate U.S.P and 28.5 mg of Clavulanic Acid as Clavulanate Potassium U.S.P

PRODUCT PACKAGING:

• 70 ml HDPE bottle with PP cap and measuring cup in a unit printed duplex board carton
• 100 ml HDPE bottle with PP cap and measuring cup in a unit printed duplex board carton

INDICATION: 

Greclav is  indicated for the treatment of the following infections in adults and children

• Lower Respiratory Infections: Caused by ß-Iactamase-producing strains of H. influenzae and M. catarrhalis.

• Upper Respiratory tract infections e.g.,

Otitis Media: Caused by ß-Iactamase-producing strains of H. influenzae and M. catarrhalis.

Sinusitis: Caused by ß-Iactamase-producing strains of H. influenzae and M. catarrhalis

Skin and Skin Structure Infections: Caused by ß-Iactamase-producing strains of S. aureus, E. coli & Klebsiella spp.

Urinary Tract Infections: Caused by ß-Iactamase-producing strains of E. coli, Klebsiella spp., and Enterobacter spp. Bone and Joint Infections e.g., osteomyelitis.